Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters

Complementary Medicines
Database
Language
Affiliation country
Publication year range
1.
Nutrients ; 15(3)2023 Jan 22.
Article in English | MEDLINE | ID: mdl-36771286

ABSTRACT

Matcha tea powder is believed to have various physiological benefits; however, its detailed mechanism of action has been poorly understood. Here, we investigated whether the mental state of mice, due to social isolation stress, affects the antidepressant-like effect of Matcha tea powder by using the tail suspension test. Oral administration of Matcha tea powder reduced the duration of immobility in the stress-susceptible C57BL/6J strain, but not in BALB/c strain. In C57BL/6J mice, SCH23390, a dopamine D1 receptor blocker, prevented Matcha tea powder from exerting its antidepressant-like effect. Matcha tea powder also increased the number of c-Fos-positive cells in the prefrontal cortex (PFC) region and the nucleus accumbens (NAc) region in C57BL/6J mice, but not in BALB/c mice. In contrast, Matcha tea powder did not change the number of c-Fos-positive cells in the ventral tegmental area (VTA) region. Notably, C57BL/6J mice with a shorter immobility time had a higher number of c-Fos-positive cells in the PFC, NAc, and VTA regions. However, no such correlation was observed in the stress-tolerant BALB/c mice. These results suggest that Matcha tea powder exerts an antidepressant-like effect through the activation of the dopaminergic system including the PFC-NAc-VTA circuit and that mental states are important factors affecting the physiological benefits of Matcha tea powder.


Subject(s)
Antidepressive Agents , Dopamine , Animals , Mice , Powders , Mice, Inbred C57BL , Antidepressive Agents/pharmacology , Social Isolation , Antioxidants , Tea
2.
Isotopes Environ Health Stud ; 47(3): 330-40, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21756199

ABSTRACT

Speciation analysis using high-performance liquid chromatography-inductively coupled plasma mass spectrometry (HPLC-ICP MS) is now commonly used to investigate metabolic and toxicological aspects of some metals and metalloids. We have developed a rapid method for simultaneous identification and quantification of metabolites of selenium (Se) compounds using multiple standards labelled with different isotopes. A mixture of the labelled standards was spiked in a selenised garlic extract and the sample was subjected to speciation analysis by HPLC-ICP MS. The selenised garlic contains γ-glutamyl-methylselenocysteine, methylselenocysteine, and selenomethionine and the concentrations of those Se compounds were 723.8, 414.8, and 310.7 ng Se ml(-1), respectively. The isotopically labelled standards were also applied to the speciation of Se in rat urine. Selenate, methylselenonic acid, selenosugar, and trimethyselenium ions were found to be excreted by the present speciation procedure. Multiple standards labelled with different stable isotopes enable high-throughput identification and quantitative measurements of Se metabolites.


Subject(s)
Chromatography, High Pressure Liquid/methods , Isotope Labeling/methods , Mass Spectrometry/methods , Selenium Compounds/analysis , Animals , Deuterium/analysis , Deuterium/metabolism , Deuterium/urine , Garlic/chemistry , Garlic/enzymology , Garlic/metabolism , Indicator Dilution Techniques/instrumentation , Indicator Dilution Techniques/standards , Isotope Labeling/standards , Isotopes/analysis , Isotopes/metabolism , Isotopes/urine , Male , Rats , Rats, Wistar , Selenium/analysis , Selenium/metabolism , Selenium/urine , Selenium Compounds/metabolism , Selenium Compounds/urine , Sensitivity and Specificity , Time Factors
3.
Toxicol Appl Pharmacol ; 226(2): 169-77, 2008 Jan 15.
Article in English | MEDLINE | ID: mdl-17988700

ABSTRACT

All nutritional selenium sources are transformed into the assumed common intermediate selenide for the syntheses of selenoproteins for utilization and/or of selenosugar for excretion. Methylselenol [monomethylselenide, MMSe] is the assumed intermediate leading to other methylated metabolites, dimethylselenide (DMSe) and trimethylselenonium (TMSe) for excretion, and also to the intermediate selenide from methylselenocysteine and methylseleninic acid (MSA). Here, related methylation and demethylation reactions were studied in vitro by providing chemically reactive starting substrates (76Se-selenide, 77Se-MMSe and 82Se-DMSe) which were prepared in situ by the reduction of the corresponding labeled proximate precursors (76Se-selenite, 77Se-MSA and 82Se-dimethylselenoxide (DMSeO), respectively) with glutathione, the three substrates being incubated simultaneously in rat organ supernatants and homogenates. The resulting chemically labile reaction products were detected simultaneously by speciation analysis with HPLC-ICP-MS after converting the products and un-reacted substrates to the corresponding oxidized derivatives (selenite, MSA and DMSeO). The time-related changes in selenium isotope profiles showed that demethylation of MMSe to selenide was efficient but that of DMSe to MMSe was negligible, whereas methylation of selenide to MMSe, and MMSe to DMSe were efficient, and that of DMSe to TMSe occurred less efficiently. The present methylation and demethylation reactions on equilibrium between selenide, MMSe and DMSe without producing selenosugar and selenoproteins indicated that DMSe rather than TMSe is produced as the end product, suggesting that DMSe is to be excreted more abundantly than TMSe. Organ-dependent differences in the methylation and demethylation reactions were characterized for the liver, kidney and lung.


Subject(s)
Organoselenium Compounds/metabolism , Selenium Compounds/metabolism , Selenium , Animals , Glutathione/metabolism , In Vitro Techniques , Isotopes , Kidney/metabolism , Liver/metabolism , Lung/metabolism , Male , Methanol/analogs & derivatives , Methylation , Organ Specificity , Oxides/metabolism , Rats , Rats, Wistar , Selenious Acid/metabolism
4.
Toxicol Appl Pharmacol ; 217(1): 51-62, 2006 Nov 15.
Article in English | MEDLINE | ID: mdl-16962623

ABSTRACT

Nutritional selenocompounds are considered to be transformed into the common intermediate selenide for utilization as selenoenzymes and/or for excretion as selenosugar and trimethylselenonium (TMSe). Therefore, selenocompounds can only be traced with a labeled selenium atom. Methylseleninic (MSA(IV)) has been proposed to be a third nutritional selenium source, the other two being inorganic selenocompounds and organic selenoamino acids, and to be a proximate selenochemical for producing the assumed biologically active form methylselenol. Here we applied a new tracer method to compare the availability and metabolism of MSA(IV) with those of three related selenocompounds under exactly identical host and tracing conditions. (82)Se-Selenite, (78)Se-selenate, (77)Se-MSA(IV) and (76)Se-methylselenonic acids (MSA(VI)) were simultaneously administered orally, each at the dose of 25 microg Se/kg body weight, to rats that had been depleted of endogenous natural abundance selenium with a single stable isotope ((80)Se). Time-related changes in the concentrations and/or distributions of the four labeled isotopes in the serum, liver, kidney, pancreas, lung and urine were determined simultaneously by inductively coupled argon plasma mass spectrometry (ICP MS) and/or HPLC-ICP MS. The availability with different isotope ratios was in the decreasing order of selenate>selenite=MSA(IV)>MSA(VI). Although selenate and MSA(VI) were distributed in organs and urine partly in their intact forms, MSA(IV) and selenite were not detected in the intact forms at all. MSA(IV) and MSA(VI) but not selenite or selenate produced TMSe in organs other than the liver, suggesting the transformation of MSA(IV) into methylselenol, and then either into selenide for the synthesis of selenoproteins and selenosugar or directly into TMSe. Thus, selenosugar and TMSe were produced widely in the organs. However, TMSe was not detected in the liver. The organ- and selenium source-specific production of TMSe was discussed as to the differences in selenium sources, and demethylation and methylation activity.


Subject(s)
Organoselenium Compounds/pharmacokinetics , Selenium Compounds/pharmacokinetics , Selenium/metabolism , Sodium Selenite/pharmacokinetics , Administration, Oral , Animals , Chromatography, High Pressure Liquid , Dealkylation , Isotopes , Male , Mass Spectrometry/methods , Methylation , Organoselenium Compounds/administration & dosage , Organoselenium Compounds/blood , Organoselenium Compounds/urine , Rats , Selenic Acid , Selenium/deficiency , Selenium Compounds/administration & dosage , Selenium Compounds/blood , Selenium Compounds/metabolism , Selenium Compounds/urine , Sodium Selenite/administration & dosage , Sodium Selenite/blood , Sodium Selenite/urine , Time Factors , Tissue Distribution
SELECTION OF CITATIONS
SEARCH DETAIL